News
September 14, 2023
Supporting the Progress of MSMEs, Phapros Allocates Partnership Funds of Rp 2.5 Billion
PT Phapros Tbk disburses partnership funds amounting to Rp 2.5 billion for 67 micro, small, and medium enterprises (MSMEs) ...
See More
August 29, 2023
The Social and Environmental Contributions of PT Phapros Tbk in the First Semester of 2023 Focus on Combating Stunting and Supporting Micro, Small, and Medium Enterprises (MSMEs).
Phapros remains fully committed to empowering Micro, Small, and Medium Enterprises (MSMEs) through its social responsibility programs in the first semester of 2023. ...
See More
August 14, 2023
The Analysts Value Phapros' Revenue Growth Better Than Other Similar Companies.
Although hit by the pandemic in 2020 and experiencing a decrease in GDP (Gross Domestic Product) growth, post-Covid-19, this figure has increased and is now in positive territory....
See More
July 27, 2023
Phapros records a growth of 14.9 percent in the Branded Pharmaceutical Products sector in the first half of 2023.
Phapros continues to target this year's performance to sustain growth. Some business lines that have been optimized this year are the sales of branded prescription drugs and exports....
See More
July 14, 2023
Reduce TB cases, Phapros launches Pro TB 2 Daily Dose.
Phapros is launching one of its new products, namely Pro TB 2 Daily Dose. This product comes in a film-coated tablet form and is intended for TB patients....
See More
June 21, 2023
69 Years of Phapros' Contribution to the Development of Indonesia's Pharmaceutical Sector
Phapros has achieved in terms of financial performance, contributions to society through the TJSL program, and the production of 500 million units of Blood Enhancing Tablets (TTD)....
See More